84.31
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Premarket
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| AbbVie Inc | ABBV | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.00 | 0.0% | 84.31 | 06:28:37 |
| Close Price | Low Price | High Price | Open Price | Previous Close |
|---|---|---|---|---|
| 84.31 |
| Stock Trades | Traded Volume | Average Volume | 52 Week Range |
|---|---|---|---|
| 1 | 7 | 7,013,432 | 62.55 - 101.48 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 06:35:07 | 7 | $ 85.48 | USD |
AbbVie Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 148.79B | 1.76B | 1.76B | $ 33.27B | $ 6.06B | 5.27 | 18.40 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 4.28 | 5.08% | - | - |
AbbVie News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ABBV Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 88.01 | 88.80 | 84.13 | 85.83 | 7,105,680 | -3.70 | -4.2% |
| 1 Month | 88.89 | 90.11 | 84.13 | 86.74 | 7,052,008 | -4.58 | -5.15% |
| 3 Months | 97.00 | 98.76 | 84.13 | 91.06 | 7,114,071 | -12.69 | -13.08% |
| 6 Months | 83.54 | 101.48 | 77.67 | 91.25 | 8,314,962 | 0.77 | 0.92% |
| 1 Year | 76.88 | 101.48 | 62.55 | 86.76 | 9,209,097 | 7.43 | 9.66% |
| 3 Years | 96.78 | 125.86 | 62.55 | 86.66 | 7,539,584 | -12.47 | -12.88% |
| 5 Years | 56.15 | 125.86 | 45.45 | 78.12 | 7,157,574 | 28.16 | 50.15% |
AbbVie Description
| AbbVie is a drug company with a strong exposure to immunology and oncology. The company's top drug, Humira, represents over half of the company's current profits. The company was spun off from Abbott in early 2013. The recent announced acquisition of Allergan will add several new drugs in aesthetics and women's health. |
